GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2020–FY 2026.

Net obligations$9.46M
Contract actions16
Awards / PIIDs5
Federal customers1
Contracting offices1
Average action$591.2K
Active fiscal years6
Data coverageFY 2020–FY 2026

Across FY 2020–FY 2026, FPDS records attribute $9.46M in net contract obligations to NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC across 16 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$2.15M
FY 2026
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2021$61.9K11—
FY 2022$5.70M31+9,109.2%
FY 2023$1.54M31−72.9%
FY 2024$011−100.0%
FY 2025$041—
FY 2026$2.15M41—

04 / Federal Customers

Which federal agencies buy from NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC?

Ranked by net obligations during FY 2020–FY 2026.

AgencyCodeObligationsActionsVendor share
7524$9.46M16100.0%

05 / Contracting Offices

Which contracting offices buy from NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC?

Ranked by net obligations during FY 2020–FY 2026.

OfficeCodeAgencyObligationsActionsVendor share
75F401FOOD AND DRUG ADMINISTRATION$9.46M16100.0%

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
541714RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$7.90M11183.5%
541715RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$1.56M5116.5%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
AN41HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH$4.26M5145.1%
AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH$3.00M5131.7%
AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH$1.52M1116.0%
AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH$634.6K116.7%
AZ12R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)$45.3K410.5%

08 / Competition Pattern

How was NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Competed$9.46M16

09 / Recent Contract Awards

What contract actions were recorded most recently for NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
75F40126C00069Sep 15, 2026$634.6KFOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS541714AJ11

10 / Interpreting the Profile

How should you evaluate NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.